When Swissmedic and US Food and Drug Administration investigators converged in March on Lantech Pharmaceuticals Ltd.’s solvent recovery facility near National Highway 16 along India’s east coast, they were on a mission to drive probable human carcinogens out of some of the world’s most popular blood pressure medications.
Enforcing A Belated Chemistry Lesson – The Nitrosamines In Sartans Saga
How authorities plan to root out the carcinogenic impurities and what it means for other classes of medicines.
